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1078–5884/00The Effect of Acute Normovolaemic Haemodilution on the
Inflammatory Response and Clinical Outcome in Abdominal
Aortic Aneurysm Repair—Results of a Pilot Trial
L. Wolowczyk,1* M. Nevin,2 A. Day,3 F.C.T. Smith,1 R.N. Baird1 and P.M. Lamont11Vascular Unit, University Department of Surgery, University Departments of 2Anaesthesiology, and
3Biochemistry, Bristol Royal Infirmary, Bristol, UKObjectives. To determine the effect of acute normovolaemic haemodilution (ANH) on the inflammatory response and
clinical outcome in elective open abdominal aortic aneurysm (AAA) repair.
Design. Randomised controlled clinical trial.
Methods. Thirty-six patients were randomised to undergo ANH or act as controls. Cell salvage was permitted in both
groups. Heterologous blood was transfused according to pre-determined triggers. Outcome measures were markers of the
systemic inflammatory response in serum and urine observed at multiple time points, and clinical recovery.
Results. Median 890 (range 670–1620) ml of blood was removed at ANH in 16 patients. There were no differences in peri-
operative changes in neutrophil count (PZ0.13), serum C-reactive protein (PZ0.38), interleukin-6 (PZ0.50), total
antioxidant capacity (PZ0.73), urinary secretion of albumin (PZ0.97) or retinol binding protein (PZ0.41). There were no
differences in the mortality and morbidity rates, systemic inflammatory response syndrome, ITU or hospital stay.
Conclusions. ANH, when used in combination with cell salvage, made no impact on systemic inflammatory response and
clinical outcome when compared to cell salvage alone after AAA repair. ANH cannot be recommended for routine use in
patients undergoing abdominal aortic aneurysm surgery when cell salvage is available.Keywords: Acute normovolaemic haemodilution; Abdominal aortic aneurysm; Inflammatory response; Clinical outcome.Peri-operative blood conservation is an important
issue in modern surgical management.1 Acute normo-
volaemic haemodilution (ANH) has been proposed as
a useful technique in reducing requirements for
heterologous blood transfusion in a variety of surgical
procedures but its clinical efficiency remains contro-
versial.2 Recent randomised clinical trials on patients
undergoing elective open AAA repair with cell
salvage showed no additional blood savings for
ANH.3,4 At present this method is used only by
enthusiasts. ANH could have other beneficial effects in
major vascular surgery. Some studies on animal
models showed that ANH can ameliorate ischaemia-
reperfusion injury in the microcirculation of the
skeletal muscle5–7 and a clinical study demonstrated
that ANH preserves renal function8 and alleviates
deleterious haemodynamic effects of aortic cross-as presented to the Vascular Surgical Society of GB&I
mber 2000 held in London.
ng author. L. Wolowczyk, 18 Baileys Mead Road,
AE, UK.
: leszekwolowczyk@hotmail.com
0012+ 08 $35.00/0 q 2005 Elsevier Ltd. All rights reserclamping in patients undergoing abdominal aortic
surgery.9
This study investigates the impact of ANH on the
inflammatory response and clinical outcome in a
randomised controlled clinical trial on patients under-
going elective open AAA repair with cell salvage
permitted in both groups.Patients and MethodsPatients
Ethical approval was granted by the South West Local
Research Ethics Committee. Forty-nine consecutive
patients scheduled to undergo elective open repair of
infra-renal AAA at the Bristol Royal Infirmary
between July 1998 and August 2000 were considered
for the trial. During this period 12 other patients with
AAAwere treated by endovascular stenting and were,
therefore, not eligible to enter the trial. Exclusion
criteria and methods including ANH procedure, cellEur J Vasc Endovasc Surg 30, 12–19 (2005)
doi:10.1016/j.ejvs.2005.02.009, available online at http://www.sciencedirect.com onved.
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described in our previous publication.3 Five patients
were excluded and a further eight did not consent
leaving 36 patients, who were randomised to undergo
ANH or standard management using a computer
generated randomisation grid in blocks of four. This
study was not on intention-to-treat basis.Assessment of systemic inflammatory response and clinical
outcome
Various recognised inflammatory markers in the
serum and urine were measured peri-operatively at
defined time intervals to quantify the severity of
surgical trauma and magnitude of the systemic
inflammatory response. Polymorphonuclear neutro-
phils have been indicated to play a pivotal role in the
pathophysiology of the local and systemic ischaemia-
reperfusion injury.10,11 Change in neutrophil count is a
non-specific but simple marker of inflammatory
response and has been used, among other parameters,
to assess outcome in research and comparative studies
on aortic surgery.12–15 C-reactive protein (CRP) is an
acute-phase protein wildly used as an indicator of
systemic response to inflammation.16 Although it is a
non-specific marker, CRP is a simple and sensitive test
and has been used to measure outcome in clinical
studies on inflammatory response to abdominal aortic
aneurysm surgery.12,17 Interleukin-6 (Il-6) is one of the
most important cytokines involved in mediation of the
systemic response to tissue injury and inflammation
and16,18,19 has been used as one of the principle
research markers of systemic inflammatory response
in AAA surgery.12,15,17,20,21 Depletion in the serum
total antioxidant capacity (TAC) in vascular surgery
has been described before and was found to correlate
well with ischaemia-reperfusion injury in both AAA
repair22 and bypass procedures for ischaemic limbs.23
Microalbuminuria is a sensitive non-specific marker of
acute and chronic systemic disease, local and systemic
inflammatory conditions, and ischaemia-reperfusion
injury.24–28 It reflects the renal glomerular component
of the systemic endothelial damage triggered by
ischaemia-reperfusion injury associated with aortic
clamping and clamp release.29 Retinol binding protein
(rbp) is a low molecular weight protein found in
serum, secreted in the renal glomerulus and reab-
sorbed in the proximal tubule. Urinary excretion of
retinol-binding protein is a marker of renal tubular
damage cause by chronic pathological conditions
affecting the kidneys and acute states characterised
by systemic inflammatory response.30–37 The assess-
ment of clinical outcome was based on the crudemortality and morbidity figures, the presence of the
systemic inflammatory response syndrome (SIRS) as
defined by ACCP/SCCM,38 and the ITU and hospital
stay. Major complications were those, which required
invasive treatment and monitoring on ITU. Minor
complications, which were treated on the ward and
did not delay hospital stay were not analysed. Patients
with uncomplicated recovery were routinely observed
overnight on ITU and discharged to the ward the next
morning. Longer than 24-h ITU stay was considered as
delayed.Laboratory techniques
Blood samples for WCC were collected pre-opera-
tively, 1 h post-operatively and then on day 1, 2, 3, 5
and 7 after surgery. The differential WCC was
performed on the ADVIA 120 analyser (Bayer Diag-
nostics) using two separate methods to achieve the
differentiation. The basophil (Baso) method provided
the primary total WCC and used the resistance of
basophils to acid lysis, which differentiates them from
the rest of the white blood cell population. The
peroxidase (Perox) method was the primary differen-
tial method, which is two-stage and uses three
reagents to stain intra-cellular myeloperoxidase and
then passes the cells through a flowcell where light
scatter and absorption is used to determine each cell’s
size and level of staining. The information was plotted
on the cytogram; cluster analysis was then employed
to determine the thresholds to separate the cell
populations.
Venous blood for CRP, Il-6 and TAC (4 ml) were
taken into the plain vacutainer tubes without addi-
tives. Samples were taken pre-operatively, pre-aortic
cross-clamping and then 1, 6, 12, 24 h after aortic cross-
clamping and on day 3 and day 7 after surgery. Blood
was allowed to clot at room temperature for 20 min
and then centrifuged at 3000 rpm for 10 min, serum
aspirated into the cryogenic aliquots (Cellstarw, Grei-
ner Labortechnik) and stored in theK70 8C freezer for
further processing. Serum C-reactive protein was
measured using a commercially available immuno-
turbidimetric assay (Randox Laboratories Ltd, UK) on
an Olympus AU600 autoanalyser (Olympus Instru-
ments, UK). The assay uses a monoclonal antibody to
CRP and its interaction with CRP is measured
turbidimetrically at 340 nm. The values were
expressed in mg/l. Serum interleukin-6 concentration
was determined by the quantitative ‘sandwich’
enzyme immunoassay (ELISA) technique using com-
mercially available kits (Biotrake human interleukin-6
[(h)Il-6] ELISA system, code RPN 2754, AmershamEur J Vasc Endovasc Surg Vol 30, July 2005
L. Wolowczyk et al.14Pharmacia Biotech, UK). Stored serum samples were
defrosted and processed according to the manufac-
turer’s protocol. Optical density was determined
spectrophotometrically using ELISA plate reader
(Labsystems Multiscan Plus) and the Il-6 concen-
tration read automatically from the standard curve
using computer software (Genesis II Windowse based
microplate software, Labsystems and Life Sciences
International (UK) Ltd). All measurements were
carried out in duplicates and the mean value was
taken. Serum Il-6 concentration was expressed in ng/l.
The Il-6 assay was performed by the main investigator
in the laboratory of the Department of Surgery at the
Bristol University and supervised by the laboratory
technicians. Serum TAC was measured using a
commercially available assay (Total Antioxidant Sta-
tus, Randox Laboratories Ltd, UK) on a Cobas Mira
analyser (Roche Laboratories Ltd, UK). The assay is
based on the reaction between the radical cation
ABTSC and serum antioxidants. ABTS (2,2 0-Azino-
di-[3-ethylbenzthiazoline sulphonate]) is incubated
with a peroxidase (metmyoglobin) and H2O2 to
produce the radical cation ABTSwC, which has a
stable blue–green colour (measured at 600 nm). Anti-
oxidants in the added sample cause suppression of
this colour to a degree, which is proportional to their
concentration. The assay is standardised using the
synthetic antioxidant Trolox and the results expressed
in mmol/l Trolox equivalents.
Urine for an albumin/creatinine and rbp/creati-
nine ratio (15–20 ml) was collected into sterile bottles
either by the patient or from the urinary catheter,
which was inserted in the anaesthetic room. Urine
samples were collected pre-operatively, pre-aortic
cross clamping, during aortic clamp, 30 min after
aortic clamp release and then 2, 4, 6, 8, 12, 24 h and 3
days post-operatively. Samples were stored in the
fridge in C4 8C until measurements according to the
assay guidelines. Urinary albumin concentrations was
measured using a commercially available immuno-
turbidimetric assay (Randox Laboratories Ldt, UK)
and urinary creatinine by standard kinetic Jaffe
method on a Kone Pro analyser (Labmedics, UK) in
parallel with albumin. Commercially available micro-
albumin and creatinine controls (Randox Laboratories
Ldt) were used and the measurements read on the
Kone Pro analyser. Urinary concentrations of albumin
were quoted as ratios to creatinine and expressed in
g/mmol. Quantification of the urinary retinol binding
protein was carried out by an ‘in-house’ ELISA
assay. The plate was coated with polyclonal rabbit
anti-human rbp antiserum. Diluted urine samples,
standards and controls were applied to plate and
incubated overnight. After washing, peroxidaseEur J Vasc Endovasc Surg Vol 30, July 2005conjugated rabbit anti-human rbp was added to
the plate followed by substrate. Controls and
samples were quantified by comparison with a
standard curve. Urinary retinol-binding protein
was expressed as ratio to creatinine and measured
in g/mmol.Statistical analysis
Populations of demographic data had normal or near-
normal distribution (age, POSSUM, AAA size) and
were expressed appropriately as mean (standard
deviation) or median (range); comparative analysis
was by parametric (Student’s t-test) or non-parametric
(Mann–Whitney U test) test. Observations of outcome
measures were taken at multiple time points. Histo-
grams and Shapiro Wilk test for normality showed
most of the variables were not normally distributed.
Instead of analysing the data at each time point a
summary measure of the individual data over time
was analysed. The summary measure used was
weighted mean, calculated by dividing the area
under curve by the time period it was measured
over, for each individual and each variable of interest.
Area under curve was calculated using the linear
trapezoidmethod andMann–WhitneyU test was used
for analysis. Proportions were analysed using Chi-
square and Fisher’s exact tests as appropriate. Peri-
operative changes of Hb concentrations within each
group (paired data) were analysed by Wilcoxon test.
Results obtained from patients who died were
included in the statistical analysis. P%0.05 was
considered statistically significant.ResultsPatients, aneurysms and grafts
Both groups were well matched for age, gender,
weight and pre-operative general health as assessed
pre-operatively by the physiological part of the
POSSUM score. In the whole cohort there were nine
active cigarettes smokers, 24 ex-smokers and three
patients who never smoked (equally distributed in the
two groups). All AAAs were infra-renal. Supra-renal
clamping requirement and the number of straight and
bifurcated grafts inserted were similar in each group
(Table 1).
Table 1. Demographics
ANH group (nZ16) Control group (nZ18) Statistical test P value
Age (years)
Median (range) 72 (55–83) 76 (60–87) Mann–Whitney 0.09
Female:male 6:10 5:13 Chi-square 0.99
Weight (kg)
Median (range) 72.5 (45–108) 78 (57–105) Mann–Whitney 0.85
POSSUM score
Media (range) 19.5 (13–32) 18.5 (12–28) Mann–Whitney 0.96
AAA size (cm)
MeanGSD 5.9G0.9 6.5G0.9 Student’s t test 0.065
Aortic clamp
Infrarenal:suprarenal 14:2 15:3 Fisher’s exact test 1.0
Grafts
Straight:bifurcated 10:6 12:6 Chi-square test 1.0
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salvage and blood transfusion
Two patients randomised into the experimental group
did not have ANH and were excluded from further
analysis. Sixteen patients underwent withdrawal of a
mean 990 (SD 256, median 890, range 670–1620) ml of
blood, which was retransfused during or shortly after
surgery. Surgical blood loss, intra-operative cell
salvage, volumes of intravenous fluids and the
requirements for heterologous blood transfusion
were similar in both groups. These results were
published in detail previously.3Systemic inflammatory response and clinical outcome
In most patients white cell count (WCC) increased 1 h
post-operatively and highest values were observed on
the 2nd day after surgery. A second rise was noted at 7
days post-operatively (Fig. 1). The peri-operative
changes of WCC did not differ between the two
groups: median (interquartile range) of 9.1 (8.8–
12.89)!109/l in the ANH group versus 8.9 (7.8–
9.6)!109/l in the control group (Mann–Whitney U
test, ZZK1.52, PZ0.13). The changes in the neutro-Fig. 1. White cell count: medians (ranges) (n!109/l).phil count (Fig. 2) paralleled the changes in WCC:
median (interquartile range) of 7.2 (6.9–10.6)!109/l in
the ANH group versus 7.0 (6.2–7.4)!109/l in the
control group (ZZK1.51, PZ0.13).
An initial drop in the serum concentration of C-
reactive protein from the pre-operative values
occurred before application of the aortic clamp and
1 h after clamp release. The concentration was only
mildly elevated at 6 h after aortic clamp release, then
increased steadily achieving maximum values at 3
days (several-fold rise from pre-op) and remained
significantly elevated at 7 days post-operatively (Fig.
3). There were large ranges in values at each time point
between individual patients. The changes of C-
reactive protein did not differ between the two groups:
median (interquartile range) 93.1 (44.1–99.2) mg/l in
the ANH versus 119.9 (70.7–134.3) mg/l in the control
group (Mann–Whitney U test, ZZ0.88, PZ0.38).
The baseline serum Il-6 concentrations were low.
An increase was observed at 1 h after aortic clamp
release. In the majority of patients, the concentration
peaked at 6 h after clamp release, remained elevated
until 24 h, decreased by day 3 and remained raised at 7
days post-operatively (Fig. 4). Three patients who
suffered serious complications (bleeding leading to
multiorgan failure, leg ischaemia and non-fatalFig. 2. Neutrophil count: medians (ranges) (n!109/l).
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Fig. 3. C-reactive protein: median (interquartile ranges). Fig. 5. Serum total antioxidant capacity ANH versus control:
median (range).
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responses between 6 and 24 h post-operatively (509,
1590 and 793 ng/l, respectively). In all other patients,
including another who had a fatal myocardial infarct,
Il-6 concentrations did not rise above 270 ng/l. There
was no evidence to suggest there was a difference in
the distribution of Il-6 between patients in the two
groups: median (interquartile range) of 44.1 (26.7–80.6)
ng/l in the ANH group versus 53.3 (32.7–71.8) ng/l in
the control group (Mann–Whitney U test, ZZ0.68, PZ
0.50).
Serum total antioxidant capacity (TAC) decreased
intra-operatively and remained low for 7 days post-
operatively with a gradual recovery to the pre-
operative levels (Fig. 5). The peri-operative changes
of serum TAC did not differ between the two groups:
median (interquartile range) of 0.944 (0.844–0.980)
mmol/l in the ANH group versus 0.906 (0.902–0.968)
mmol/l in the control group (Mann–Whitney U test,
ZZK0.34, PZ0.73).
Albuminuria increased during surgery achieving
maximum urinary albumin/creatinine ratios within
2 h after aortic clamp release and then quickly
decreased post-operatively (Fig. 6). Marked variation
in absolute values between individual patients in both
groups were observed at most time points. There was
no statistical difference in the peri-operative albumi-Fig. 4. Interleukin-6 in AAA repair ANH versus control
group: median (interquartile range).
Eur J Vasc Endovasc Surg Vol 30, July 2005nuria between the two groups: median (interquartile
range) of 10.86 (4.32–29.13)!10K6 g/mmol in the ANH
group versus 13.35 (6.96–29.80)!10K6 g/mmol in the
control group (Mann–Whitney U test, ZZ0.042, PZ
0.97).
The urinary excretion of retinol binding protein
increased peri-operatively in all patients and remained
elevated at 3 days post-operatively but there was no
consistent time point for the peak values and the
individual traces often followed a seesaw pattern
(Fig. 7). There was no statistical difference in the
peri-operative excretion of retinol binding protein
between the two groups: median (interquartile
range) of 6.28 (1.59–7.78)!10K6 g/mmol in the ANH
group versus 2.66 (0.05–7.26)!10K6 g/mmol (Mann–
Whitney U test, ZZK0.83, PZ0.41).
There was one death (from multiorgan failure) and
three major post-operative complications (two myo-
cardial infarcts, one left ventricular failure) in the
ANH group versus two deaths (one from myocardial
infarct, one from leg ischaemia in a patient who
refused further surgery) and four major complications
(one respiratory failure, one acute renal failure, two
acute left ventricular failures) in the control group
(Fisher’s exact test, PZ0.98). In the survivors SIRS was
observed in the post-operative period in 10/15 in theFig. 6. Albuminuria in AAA repair: ANH versus controls
medians (interquartile ranges).
Fig. 7. Urinary retinal binding protein/creatinine: ANH
versus controls medians (interquartile ranges).
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square test, PZ1.0). The severity of symptoms varied
between individuals and ranged from single episodes
of tachycardiaG tachypnoeaG pyrexiaO38 8C during
otherwise uncomplicated post-operative recovery to
prolonged periods of tachycardia associated with
leukocytosis in patients with multiorgan failure.
In the ANH group 4/15 patients had prolonged ITU
stay and one was readmitted to ITU from the ward. By
comparison, in the control group 3/16 had prolonged
ITU stay (including deaths) and the difference was
statistically not significant (Chi-square test, PZ0.99).
The median (range, meanGSD) hospital stay was 11
(7–22, 12G4.4) days in the ANH group versus 13 (7–25,
12G5.3) days in the control group and the difference
was not significant (Mann–Whitney U test, PZ0.98).Discussion
In our previous study3 based on the same series of
patients we showed that ANH in AAA surgery did not
incur any demonstrable savings on the requirements
for bank blood. We discussed possible reasons for this
result. The important finding of this study is that
ANH, when used in combination with cell salvage in
open AAA repair, did not exert any demonstrable
effect on the systemic inflammatory response and
clinical outcome, when compared to cell salvage alone.
This negative result may relate to similar requirements
for heterologous blood transfusion in the two groups
of patients. Small number of patients invalidated
comparative analysis of subgroups. Large volumes of
blood (mean 990 ml) were withdrawn at the ANH
procedure to ensure significant impact on outcome
measures. It is remarkable that the majority of patients
in the experimental group tolerated the ANH pro-
cedure well. They were older than cohorts of patients
in other reports on ANH during abdominal aortic,8
cardiac39 or non-vascular surgery40–42 and many hadcardiac comorbidities. Two patients became cardio-
vascularly unstable during ANH and we agree with
previous suggestions39,41,43 that suitability to ANH
should be based on the assessment of cardiovascular
reserve rather than chronological age.
The general patterns of the peri-operative traces of
the inflammatory markers were consistent with those
reported in other studies on AAA repair.17,20,27,28,44,45
Large variations were observed in the individual
responses of serum Il-6, C-reactive protein, neutrophi-
lia, and urinary excretion of albumin and retinol
binding protein. This variability may result from the
differences in the magnitude of surgical insult as well
as the responsiveness of the host’s immune system.
Urinary secretion of retinol binding protein is a
recognised marker of ischaemia-reperfusion injury
and has been used in research to evaluate renal
damage in cardiac surgery37 and renal transplan-
tation36 but, unlike albuminuria, has not been
measured in AAA surgery before. Systemic inflam-
matory response syndrome was observed in two
thirds of patients in both groups, which is higher
than in other reports46 and the magnitude of clinical
response varied markedly. We have previously high-
lighted that SIRS, while being a useful clinical
indicator of the inflammatory response to an insult
with a clear definition,47 needs to be developed into a
more discriminatory system consisting of clinical and
biochemical parameters if it is to be used as a valuable
research tool.48
Our previous3 and present studies suggest that
routine use of ANH does not save bank blood and
does not improve the inflammatory response or
clinical outcome in AAA surgery. These results are
disappointing and do not support routine use of ANH
in major vascular surgery, when cell salvage is
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